MACD(12,26,9) Bull Crossover Stocks (Jun.12)

NASDAQ: GERN (Geron Corp)

JNJ’s Janssen was granted FDA orphan designation for its imetelstat for the treatment of myelofibrosis — GERN is parterned with Janssen for the drug (GERN).

GERN has closed at $4.05, its traded Volume was 7008.9K shares, GERN opened the Day at $3.86, it made an intraday Low of $3.83, and an intraday High of $4.18. GERN (Geron Corp) 52-week High is $4.49, 52-week Low is: $1.76, it has supports at $3.87 and $3.51, resistances at $4.46 and $5.2. GERN’s earning is $-0.23 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is -18. Overall, this stock is rated STRONG BUY today.

NYSE: ORCL (Oracle Corp)

Oracle’s could produce better results for the just-completed quarter as the company transitions its software business to the cloud, where it can better compete with fast-growing rivals Salesforce.com (NYSE:CRM) and Workday (NYSE:WDAY), which last month gave disappointing Q2 guidance.

ORCL has closed at $44.34, its traded Volume was 11742.3K shares, ORCL opened the Day at $43.98, it made an intraday Low of $43.9, and an intraday High of $44.39. ORCL (Oracle Corp) 52-week High is $46.421, 52-week Low is: $35.598, it has supports at $43.23 and $42.2, resistances at $44.9 and $52.44. ORCL’s earning is $2.39 per share, Next quarter estimated EPS is $0, current year estimated EPS is $1.06. Its PE ratio is 19. Overall, this stock is rated STRONG BUY today.

NYSE: VIPS (Vipshop Holdings Limited)

Sell-side Wall Street analysts are anticipating Vipshop Holdings Limited (NYSE:VIPS) will post a current quarter earnings per share of $0.11. This figure is based on the combined estimates of the analysts that cover the company.

VIPS  has closed at $25.35, its traded Volume was 6605.57K shares, VIPS opened the Day at $24.23, it made an intraday Low of $24.21, and an intraday High of $25.66. VIPS (Vipshop Holdings Limited) 52-week High is $30.72, 52-week Low is: $16.95, it has supports at $22.7 and $18.88, resistances at $27.65 and $30.71. VIPS’s earning is $0.28 per share, Next quarter estimated EPS is $0, current year estimated EPS is $0. Its PE ratio is 91. Overall, this stock is rated BUY today.